# Ostoform

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ostoform

- Industry: Medical Devices & Equipment
- Headquarters: Dublin, Ireland
- Website: www.ostoform.com
- Total disclosed funding: $4.4M
- Latest round: Series A (Oct 19, 2021)
- Investors on record: 4

## About

Ostoform Limited is a healthcare company specializing in innovative ostomy care solutions, focusing on products designed to enhance user comfort and improve outcomes for individuals with ostomies.Founded in 2016 and headquartered in Dublin, Ireland, Ostoform Limited develops ostomy care products aimed at improving the quality of life for ostomy users. The company has executed a total of 2 deals, with its most recent funding round, a Series A, occurring on October 19, 2021, where it raised EUR 2.70 million. The lead investor for this round was Business Growth Fund, with participation from Enterprise Ireland, Halo Business Angel Network, and SOSV. The company's current valuation stands at EUR 8.995 mn, reflecting its growing market presence under the leadership of CEO Kevin Kelleher.Ostoform Limited specializes in innovative ostomy care solutions, primarily focusing on its flagship product, the FLOWASSIST Seal, which incorporates patented FLOWASSIST technology. This non-absorbent component effectively directs stoma output away from the skin and into ostomy pouches, thereby reducing the risk of skin complications associated with high liquid output. The FLOWASSIST Seal along with the FLOWASSIST 2-Piece Pouch enhances the quality of life for ostomy users by preventing leaks and minimizing the frequency of appliance changes. These products are marketed mainly in the United States, Republic of Ireland, and various regions globally, targeting both direct consumers and healthcare facilities.Ostoform Limited generates revenue through the direct sales of its ostomy products including the FLOWASSIST Seal and the FLOWASSIST 2-Piece Pouch to consumers and healthcare providers. The business model includes B2B transactions with hospitals and healthcare facilities, which stock these products to benefit their patients. The pricing structures are designed to ensure accessibility for users while maintaining high-quality standards. The company has built a reputation for quality and reliability in ostomy care since its inception.In October 2021, Ostoform Limited raised EUR 2.70 million in venture funding to capitalize on international growth opportunities for its existing and pipeline products. The funding will facilitate the expansion into new markets, specifically aiming to enhance its presence in North America and Europe by the end of 2023, as well as support the development and launch of upcoming product lines designed to further improve user experience.

## Funding rounds

- Series A, Oct 19, 2021, $3.1M — Enterprise Ireland, BGF Investment Management, SOSV, Halo Business Angel Network
- Series A, Oct 1, 2018, $1.3M — Enterprise Ireland, SOSV, Halo Business Angel Network

## Investors

- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Series A
- SOSV (https://capitalatlas.ai/funds/sosv) — Series A
- Halo Business Angel Network — Series A
- BGF Investment Management (https://capitalatlas.ai/funds/bgf-investment-management) — Series A